M. D. Nolfo

Effect of the Etiology of Viral Cirrhosis on the Survival of Patients with Hepatocellular Carcinoma

M. Zoli, F. Farinati, F. Trevisani, 2006, The American Journal of Gastroenterology.

Diagnostic and Prognostic Role of α-Fetoprotein in Hepatocellular Carcinoma: Both or Neither?

M. Zoli, F. Farinati, F. Trevisani, 2006, The American Journal of Gastroenterology.

Transarterial chemoembolization in Child–Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea

M. Zoli, E. Giannini, F. Farinati, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)

M. Zoli, F. Farinati, F. Trevisani, 2002, American Journal of Gastroenterology.

109 CLINICAL VALIDATION OF A SUB-STAGING PROPOSAL OF PATIENTS WITH INTERMEDIATE HCC (BCLC-B)

M. Zoli, L. Bolondi, F. Piscaglia, 2013 .

Surveillance for Early Diagnosis of Hepatocellular Carcinoma: Is It Effective in Intermediate/Advanced Cirrhosis?

M. Zoli, V. Santi, E. Giannini, 2007, The American Journal of Gastroenterology.

Surveillance for Hepatocellular Carcinoma in Elderly Italian Patients With Cirrhosis: Effects on Cancer Staging and Patient Survival

M. Zoli, F. Farinati, F. Trevisani, 2004, American Journal of Gastroenterology.

Ten-Year Outcome of Radiofrequency Thermal Ablation for Hepatocellular Carcinoma: An Italian Experience

M. Zoli, E. Giannini, F. Farinati, 2012, The American Journal of Gastroenterology.

Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population.

M. Zoli, A. Cucchetti, E. Giannini, 2012, Journal of hepatology.

Impact of evidence‐based medicine on the treatment of patients with unresectable hepatocellular carcinoma

M. Zoli, E. Giannini, F. Farinati, 2010, Alimentary pharmacology & therapeutics.